id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-266147-s8rxzm0t	Burnouf, Thierry	Modern Plasma Fractionation	2007-03-28		.txt	text/plain	8837	376	35	An updated list of the major therapeutic applications of plasma protein products can be found elsewhere. Modern plasma product production technology remains largely based on the ethanol fractionation process, but much has evolved in the last few years to improve product purity, to enhance the recovery of immunoglobulin G, and to isolate new plasma proteins, such as α1-protease inhibitor, von Willebrand factor, and protein C. Because of the human origin of the starting material and the pooling of 10 000 to 50 000 donations required for industrial processing, the major risk associated to plasma products is the transmission of blood-borne infectious agents.	cache/cord-266147-s8rxzm0t.txt	txt/cord-266147-s8rxzm0t.txt
